Cutler Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-32,300
Closed -$50K 3795
2023
Q1
$50K Sell
32,300
-8,000
-20% -$228K 0.01% 1352
2022
Q4
$15K Buy
40,300
+30,900
+329% +$1.41M ﹤0.01% 2427
2022
Q3
$20K Sell
9,400
-2,600
-22% -$133K ﹤0.01% 2610
2022
Q2
$15K Sell
12,000
-4,500
-27% -$223K ﹤0.01% 2901
2022
Q1
$52K Buy
16,500
+13,400
+432% +$917K ﹤0.01% 2215
2021
Q4
$82K Hold
3,100
﹤0.01% 2008
2021
Q3
$160K Hold
3,100
0.01% 1543
2021
Q2
$162K Sell
3,100
-500
-14% -$67.3K 0.01% 1492
2021
Q1
$256K Sell
3,600
-300
-8% -$45.3K 0.01% 1113
2020
Q4
$192K Buy
3,900
+700
+22% +$80.5K 0.01% 1111
2020
Q3
$151K Sell
3,200
-100
-3% -$9.15K 0.01% 1067
2020
Q2
$86K Sell
3,300
-7,500
-69% -$604K 0.01% 1401
2020
Q1
$81K Buy
10,800
+7,800
+260% +$599K ﹤0.01% 1448
2019
Q4
$83K Buy
3,000
+100
+3% +$7.21K 0.01% 1297
2019
Q3
$54K Buy
2,900
+500
+21% +$44K ﹤0.01% 1478
2019
Q2
$21K Buy
+2,400
New +$183K ﹤0.01% 2164

Other funds holding GH

Cutler Group's GH Position: Q1 2023 in Review

Cutler Group sold out of Guardant Health (GH) in Q1 2023, closing a stake of 2,917 shares — an estimated $83.3K sold.

Cutler Group first reported a position in GH in Q3 2019 and held it in 8 quarters. The position peaked at $777K in Q3 2022. 278 funds tracked by Wall St. Rank hold GH as of Q1 2023.

  • Cutler Group reported no remaining Guardant Health position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 2,917 Guardant Health shares in Q1 2023, an estimated $83.3K.
  • Cutler Group first reported a position in Guardant Health in Q3 2019 and held it in 8 quarters.
  • Cutler Group's Guardant Health position peaked at $777K in Q3 2022.
  • 278 funds tracked by Wall St. Rank held Guardant Health as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.